Correlation Between SciVision Biotech and Pegavision

Can any of the company-specific risk be diversified away by investing in both SciVision Biotech and Pegavision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SciVision Biotech and Pegavision into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SciVision Biotech and Pegavision, you can compare the effects of market volatilities on SciVision Biotech and Pegavision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SciVision Biotech with a short position of Pegavision. Check out your portfolio center. Please also check ongoing floating volatility patterns of SciVision Biotech and Pegavision.

Diversification Opportunities for SciVision Biotech and Pegavision

0.9

Correlation Coefficient

SciVision Biotech  Pegavision

Almost no diversification

The 3 months correlation between SciVision and Pegavision is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding SciVision Biotech and Pegavision in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pegavision and SciVision Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SciVision Biotech are associated (or correlated) with Pegavision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pegavision has no effect on the direction of SciVision Biotech i.e., SciVision Biotech and Pegavision go up and down completely randomly.

Pair Corralation between SciVision Biotech and Pegavision

Assuming the 90 days trading horizon SciVision Biotech is expected to under-perform the Pegavision. In addition to that, SciVision Biotech is 1.43 times more volatile than Pegavision. It trades about -0.21 of its total potential returns per unit of risk. Pegavision is currently generating about -0.15 per unit of volatility. If you would invest  42,100  in Pegavision on September 24, 2024 and sell it today you would lose (6,600) from holding Pegavision or give up 15.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

SciVision Biotech  vs.  Pegavision

SciVision Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SciVision Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pegavision

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pegavision has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with SciVision Biotech and Pegavision

The main advantage of trading using opposite SciVision Biotech and Pegavision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SciVision Biotech position performs unexpectedly, Pegavision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pegavision will offset losses from the drop in Pegavision's long position.

The idea behind SciVision Biotech and Pegavision pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.